Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of Adverse Events Between PARP Inhibitors in Patients with Epithelial Ovarian Cancer: A Nationwide Propensity Score Matched Cohort Study.
Target Oncol. 2024 Mar;19(2):251-262. doi: 10.1007/s11523-024-01037-0. Epub 2024 Feb 28.
Target Oncol. 2024.
PMID: 38416378
NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells.
Yun H, Han GH, Kim J, Chung JY, Kim JH, Cho H.
Yun H, et al.
J Cell Mol Med. 2022 Oct;26(20):5277-5291. doi: 10.1111/jcmm.17557. Epub 2022 Sep 16.
J Cell Mol Med. 2022.
PMID: 36114703
Free PMC article.
Item in Clipboard
Cite
Cite